ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight

ClinicalTrials.gov ID: NCT05929066

Public ClinicalTrials.gov record NCT05929066. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:42 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Master Protocol to Investigate the Efficacy and Safety of LY3437943 Once Weekly in Participants Without Type 2 Diabetes Who Have Obesity or Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (TRIUMPH-1)

Study identification

NCT ID
NCT05929066
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
2,300 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Retatrutide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 9, 2023
Primary completion
Mar 31, 2026
Completion
Apr 30, 2026
Last update posted
Apr 17, 2025

2023 – 2026

United States locations

U.S. sites
39
U.S. states
24
U.S. cities
36
Facility City State ZIP Site status
Central Phoenix Medical Clinic Phoenix Arizona 85020
Arizona Research Center Phoenix Arizona 85053
Medical Investigations Little Rock Arkansas 72211
Neuro-Pain Medical Center Fresno California 93710
Valley Research Fresno California 93720
Artemis Institute for Clinical Research San Diego California 92103
University of Colorado Anschutz Medical Campus Aurora Colorado 80045
Yale University School of Medicine New Haven Connecticut 06519
Chase Medical Research, LLC Waterbury Connecticut 06708
Teradan Clinical Trials, LLC Brandon Florida 33511
Suncoast Research Group Miami Florida 33135
New Horizon Research Center Miami Florida 33165
Clinical Neuroscience Solutions Orlando Florida 32801
Progressive Medical Research Port Orange Florida 32127
NeuroTrials Research Inc Atlanta Georgia 30328
North Georgia Clinical Research Woodstock Georgia 30189
East-West Medical Research Institute Honolulu Hawaii 96814
Northwestern University Chicago Illinois 60611
Central Illinois Diabetes and Clinical Research a Division of Prairie Education and Research Cooperative Springfield Illinois 62711
Brengle Family Medicine Indianapolis Indiana 46260
Cotton O'Neil Diabetes & Endocrinology Topeka Kansas 66606
MedVadis Research Corporation Waltham Massachusetts 02451
Great Lakes Research Group, Inc. Bay City Michigan 48706
StudyMetrix Research City of Saint Peters Missouri 63303
Clinvest Research LLC Springfield Missouri 65807
Palm Research Center Tenaya Las Vegas Nevada 89128
Rochester Clinical Research, LLC Rochester New York 14609
Carteret Medical Group Morehead City North Carolina 28557
Trial Management Associates - Wilmington - Floral Parkway Wilmington North Carolina 28403
Lillestol Research Fargo North Dakota 58104
Altoona Center For Clinical Research Duncansville Pennsylvania 16635
Tribe Clinical Research, LLC Greenville South Carolina 29607
Tribe Clinical Research - Spartanburg Spartanburg South Carolina 29301
Vanderbilt Health One Hundred Oaks Nashville Tennessee 37204
FutureSearch Trials of Neurology Austin Texas 78731
Juno Research Houston Texas 77040
Advanced Research Institute Ogden Utah 84405
Northwest Clinical Research Center Bellevue Washington 98007
Rainier Clinical Research Center Renton Washington 98057

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 95 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05929066, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 17, 2025 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05929066 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →